|
Volumn 75, Issue 5, 2000, Pages 2172-2177
|
Tissue plasminogen activator requires plasminogen to modulate amyloid-β neurotoxicity and deposition
a a a a a
a
NONE
(United States)
|
Author keywords
Alzheimer's disease; Amyloid; Apoptosis; Protease; Tissue plasminogen activator
|
Indexed keywords
AMYLOID BETA PROTEIN;
BENZYLSULFONYL FLUORIDE;
PLASMINOGEN;
PLASMINOGEN ACTIVATOR;
SERINE PROTEINASE INHIBITOR;
ALZHEIMER DISEASE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
APOPTOSIS;
ARTICLE;
CONTROLLED STUDY;
NERVE CELL NECROSIS;
NEUROTOXICITY;
NONHUMAN;
OXIDATIVE STRESS;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
RAT;
STROKE;
AMYLOID BETA-PROTEIN;
ANIMAL;
CELL DEATH;
CELLS, CULTURED;
DRUG SYNERGISM;
ENZYME INHIBITORS;
MICROSCOPY, ELECTRON;
NEURONS;
NEUROPROTECTIVE AGENTS;
PHENYLMETHYLSULFONYL FLUORIDE;
PLASMIN;
PLASMINOGEN;
RATS;
SUPPORT, NON-U.S. GOV'T;
TISSUE PLASMINOGEN ACTIVATOR;
|
EID: 0033788789
PISSN: 00223042
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1471-4159.2000.0752172.x Document Type: Article |
Times cited : (102)
|
References (26)
|